Dr Nicola Davies’ Post

View profile for Dr Nicola Davies, graphic

Behavioural Science & Pharmaceutical / Life Science Consultant; Keeping digital health human-centred / TV Guest Expert / Author

FirstWord Pharma spoke with Rashme Cardoza, Global Medical Affairs Consultant, formerly at GSK, about the future of pharma’s advisory boards and how their evolution is driving greater collaboration and innovation within the pharmaceutical industry. A few takeaways: 👩💻 Leveraging technology has revolutionized pharma's approach to seeking expertise and insights, allowing for greater accessibility, diversity, real-world evidence, and patient involvement, whilst being flexible and cost-effective. ⚕ This highlights the growing role of Medical Affairs, with a more strategic contribution to overall business decisions. 📏 Engagement metrics, reach, accessibility and decision impact are key to measuring effectiveness of virtual advisory boards. Read the full report here: https://lnkd.in/esktTKcE It was a pleasure interviewing you, Rashme Cardoza!

ViewPoints: Beyond the boardroom — the rise of virtual and patient-inclusive pharma advisory boards

ViewPoints: Beyond the boardroom — the rise of virtual and patient-inclusive pharma advisory boards

ml.firstwordpharma.com

Mark Duman MRPharmS

Patient Engagement Expert | Masterclasses, workshops, strategic consulting for healthcare and life sciences (+PwT2D)

8mo

Can’t access it

Like
Reply

To view or add a comment, sign in

Explore topics